This is not legal or medical advice. Pharmaceutical companies, along with Xarelto, should warn the patients using appropriate labeling about the possible side-effects of it. This standard is same and applies to every drug manufacturer company.
While bleeding is a common side-effect of anticoagulants, it has been reported that xarelto lawsuits is very dangerous. That simply means, that patients inhaling Xarelto at certain emergency situations are at serious risks of permanent bleeding problems, which may lead to life-threatening issues and other gastrointestinal hemorrhaging.
What are the possibilities that a sufferer can be entitled to compensation?
The plaintiffs in these lawsuits may seek compensation for the past and future medical bills, lost wages, suffering and pain and, in cases of death, funeral payments. Also, they are seeking punitive damages, which are usually awarded to punish the litigant and hinder other companies from acting similarly.
Why are lawsuits being filed?
Several cases have examined that the use of Xarelto is unsafe and is potentially dangerous for the overall health of the consumers. The plaintiffs claim that, dissimilar to traditional anticoagulants (e.g. warfarin, Coumadin) whose blood thinning effects can be inversed using vitamin K, no antidote for Xarelto is available that could reverse its blood thinning effects. The lawsuits filed against the false labeling and potential side-effects claim that doctors have no possible means of stopping at times of an emergency. Here are a few possible reasons for people filing the lawsuits -
The manufacturers of the drug continue to market Xarelto as a risk-free anticoagulant alternative.
Doctors and medical staff were not made aware of techniques to stabilize and treat a Xarelto user in the act of a bleeding complication.
Xarelto users were not cautious of the health risks of suffering a fatal bleeding event.
xarelto lawsuits is associated with severe bleeding complications, redundant blood loss, and wound infections from inhibited clotting, intracranial hemorrhaging, stomach bleeding, eye bleeding (vitreous hemorrhage), gastrointestinal bleeding, and inability to prevent users from dangerous clotting.